Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?

被引：0
|
作者：
Gianfranco Ferraccioli
Barbara Tolusso
Elisa Gremese
机构：
[1] Catholic University of the Sacred Heart,Institute of Rheumatology, School of Medicine
[2] Catholic University of the Sacred Heart,Institute of Rheumatology, Fondazione Policlinico Gemelli
来源：
Arthritis Research & Therapy | / 18卷
关键词：
Rituximab; Low dose; High dose; Synovial tissue B cell depletion; Peripheral B cell depletion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The CERERRA database provides evidence that low-dose rituximab performs as well as the conventional dose in the real world, thus highlighting the possible pharmacoeconomic impact. In clinical trials, it has been shown that rituximab 500 mg twice, performs as well as 1 g twice, 2 weeks apart, in terms of the American College of Rheumatology (ACR)20 and ACR50, but not the ACR70. The choice should always be made after considering that the IMAGE trial has demonstrated similar radiographic progression after the first 6 months, but with less control, with low-dose rituximab in the first 6 months. A possible alternative can be hypothesized.
引用
收藏
相关论文
共 50 条
  • [1] Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?
    Ferraccioli, Gianfranco
    Tolusso, Barbara
    Gremese, Elisa
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [2] REGIME OF USE OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN DAILY CLINICAL PRACTICE
    Merino-Melendez, L.
    Llorente-Cubas, I.
    Velasco, T.
    Castaneda, S.
    Alvaro-Gracia, J.
    Gonzalez-Alvaro, I.
    Sala, L.
    Garcia-Vicuna, R.
    Garcia-Vadillo, A.
    Lopez-Bote, J. P.
    Lopez-Lopez, J.
    Herrera, F. S.
    Munoz-Calleja, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 949 - 949
  • [3] Comments on the use of vitamin D in clinical practice, pros and cons
    Mowry, E.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 12 - 12
  • [4] Regime of Use of Rituximab in Patients with Rheumatoid Arthritis in Daily Clinical Practice.
    Merino-Melendez, Leticia
    Llorente, Irene
    Castaneda, Santos
    Velasco, Teresa
    Sala-Icardo, Luis
    Garcia-Vicuna, Rosario
    Garcia-Vadillo, Alberto
    Lopez-Bote, Juan P.
    Lopez-Lopez, Jorge
    Herrera, Federico
    Munoz-Calleja, Cecilia
    Alvaro-Gracia, J. M.
    Gonzalez-Alvaro, Isidoro
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1051 - S1052
  • [5] USE OF RITUXIMAB TO TREAT RHEUMATOID ARTHRITIS AND FOCAL SEGMENTAL GLOMERULAR SCLEROSIS
    Williams, Mark R.
    Adizie, Tochukwu
    Dasgupta, Bhaskar
    RHEUMATOLOGY, 2012, 51 : 156 - 156
  • [6] How well do we treat patients with rheumatoid arthritis? Towards benchmarking in clinical practice
    Taylor, J.
    Thompson, P.
    Richards, S.
    Cornell, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 663 - 663
  • [7] Dose reduction of rituximab in clinical practice: a retrospective cohort study of rheumatoid arthritis patients in low disease activity on rituximab
    Wientjes, M. H. M.
    van Huissteden, J.
    van Herwaarden, N.
    Verhoef, L. M.
    den Broeder, A. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (11) : 2215 - 2220
  • [8] Rituximab in rheumatoid arthritis: Defining its role in daily clinical practice
    Dale, James
    Stirling, Anne
    Johnston, Louise
    Gordon, Margaret-Mary
    RHEUMATOLOGY, 2008, 47 : II33 - II33
  • [9] Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice
    Takanashi, Satoshi
    Kaneko, Yuko
    Takeuchi, Tsutomu
    RHEUMATOLOGY, 2021, 60 (11) : 5247 - 5256
  • [10] DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS IN THE CLINICAL PRACTICE OF A RHEUMATOLOGY CENTER
    Gordeev, A.
    Matianova, E.
    Olyunin, Y.
    Galushko, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1239 - 1239
12345